Bell David J, Molyneux Malcolm E
Malawi-Liverpool Wellcome Trust Clinical Research Program, and Department of Medicine, College of Medicine, University of Malawi and Liverpool School of Tropical Medicine, Liverpool, UK.
Expert Rev Anti Infect Ther. 2007 Feb;5(1):141-52. doi: 10.1586/14787210.5.1.141.
Malaria continues to be a major cause of mortality and morbidity in tropical countries. Infection with Plasmodium falciparum may be asymptomatic, cause an uncomplicated febrile illness or give rise to severe disease complicated by coma, acidosis or severe anemia. Treatment of the febrile illness with two drugs--preferably in the form of an artemisinin-containing combination therapy--is now widely recommended, both for greater efficacy and in order to delay the evolution of drug resistance. The clinical picture of severe malaria differs according to the age and immune status of the individual; treatment requires a range of supportive measures, as well as an efficacious antimalarial drug. Insecticide-treated bednets and presumptive treatment programs are increasingly deployed in malaria control programs, while vaccines are showing promise.
疟疾仍然是热带国家死亡和发病的主要原因。感染恶性疟原虫可能没有症状,引起无并发症的发热性疾病,或导致伴有昏迷、酸中毒或严重贫血的严重疾病。目前广泛推荐使用两种药物治疗发热性疾病——最好采用含青蒿素的联合疗法——这既是为了提高疗效,也是为了延缓耐药性的发展。重症疟疾的临床表现因个体年龄和免疫状况而异;治疗需要一系列支持措施以及有效的抗疟药物。在疟疾控制项目中,经杀虫剂处理的蚊帐和推定治疗方案的使用越来越多,同时疫苗也显示出前景。